Skip to main content
Premium Trial:

Request an Annual Quote

'10 Completely Separate Diseases'

Premium

A new study published in Nature says breast cancer should be split into 10 separate subtypes, reports BBC News' James Gallagher. The international groups of researchers analyzed the genomes and transcriptomes of 2,000 breast tumors, and developed a method for molecular stratification of the disease, based on their findings. "Researchers compared breast cancer to a map of the world. They said tests currently used in hospitals were quite broad, splitting breast cancer up into the equivalent of continents," Gallagher writes. "The latest findings give the breast cancer map far more detail, allowing you to find individual 'countries.'" Not only are there genetic differences in the subtypes, but also differences in survival times for patients, he adds.

Though it may take years for this information to be used in the clinic, the researchers tell the BBC that they are hopeful that their findings will lead to a new way to diagnose and treat breast cancer.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.